Fundz

Fundz Deep Dive

Everything you need to win Cizzle Biotechnology Holdings plc — in one platform.

Who to reach, what to say, and why now on Cizzle Biotechnology Holdings plc — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Cizzle Biotechnology Holdings plc — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Cizzle Biotechnology signs exclusive licensing and partnership agreement for North America

Oct 21, 2024•over 1 year ago

Contract Type

partnership

LondonBiotechnologyHealth Care

Description

Cizzle Biotechnology Holdings plc has signed an exclusive licensing and partnership agreement for its CIZ1B biomarker test with Cizzle Bio Inc (BIO) to help detect early-stage lung cancer in the USA and Canada. The agreement includes an upfront royalty payment of US$300,000, along with guaranteed minimum royalty payments totaling US$2 million over the next 30 months.

Company Information

Company

Cizzle Biotechnology Holdings plc

Location

London, England, United Kingdom

About

Cizzle Biotechnology Holdings plc, based in the UK, is a diagnostics developer focusing on bringing non-invasive and cost-effective lung cancer blood tests to the market.

Predictive Intelligence
Strategic

ML-powered predictions for Cizzle Biotechnology Holdings plc's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.